Making Sense of Severe Lupus: How the SLE-DAS Tool Could Improve Care Outcomes
In this episode of the Lupus Foundation of America podcast, Jaren Crump sits down with Dr. Luís Inês, rheumatologist and President of the European Lupus Society, about new research that could change h...
4 Elo 202517min
Inside Lupus: The Potential of Genetic Endotypes to Personalize Lupus Care
In this episode of the Lupus Science and Medicine Podcast, host Dr. Anna Wolska speaks with Dr. Amerie Grammer about how genetic breakthroughs are paving the way for personalized lupus care. Researche...
7 Heinä 202515min
Empowering Lupus Patients: A Treatment Measure Shaped by Their Voices
In this podcast, Dr. Anna Wolska sits down with Dr. Eric Morand to discuss a groundbreaking effort to improve how lupus treatment success is measured in clinical trials. Dr. Morand explains why existi...
7 Touko 202518min
Steroid Use for the Treatment of Lupus Nephritis
Lupus nephritis, affecting nearly half of lupus patients, can cause severe kidney damage. Traditionally, high-dose glucocorticoids (~1 mg per kg prednisone) have been used despite significant side eff...
7 Huhti 202512min
Validating Claims Algorithms for SLE: Geospatial Insights and Impacts on Health Disparities
Join Dr. Anna Wolska from the Lupus Foundation of America as she talks with Dr. Jim Oates about his recently published study in Lupus Science & Medicine on validating claims-based algorithms in Medica...
3 Maalis 202513min
Rethinking Lupus Nephritis Treatment: Voclosporin vs. High-Dose Steroids
Early reduction in proteinuria is a key predictor of improved long-term kidney health in lupus nephritis (LN). In this episode, Dr. Anna Wolska from the Lupus Foundation of America speaks with Drs. Ma...
3 Helmi 202545min
Rituximab in Childhood Lupus: Insights and Safety
Join Dr. Anna Wolska and Dr. Jordan Roberts, a pediatric rheumatologist, as they explore the use of Rituximab in treating childhood-onset systemic lupus erythematosus (SLE). They discuss key factors f...
6 Tammi 202515min
